"The CHAMPION MG Study – a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Ravulizumab, a Long-Acting Complement Inhibitor, for Myasthenia Gravis"
Amro Stino, M.D.
Clinical Assistant Professor, Neurology
Director, Peripheral Neuropathy Clinic
Co-Director, Autonomic Lab
